Skip to content

Management of Postoperative Pain After Total Knee Arthroplasty

Analgesic Effects of Intraarticular Bupivacaine in Patients Receiving Total Knee Arthroplasty

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000463572
Enrollment
40
Registered
2015-05-12
Start date
2012-12-10
Completion date
2013-03-25
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Analgesic effects of intravenous parecoxib have been investigated in orthopedic surgery. Postoperative pain is still a common problem after total knee arthroplasty. Recent studies have shown that intraarticular bupivacaine injection has analgesic effect after total hip replacement and good opioid-sparing effect at the first 12 hours after hip surgery. Local anesthetic is injected into intraarticular cavity after surgical wound closure, spreading into muscle and soft tissue, which can effectively decrease postoperative pain. In view of this, we hypothesized that intraarticular bupivacaine in combination with intravenous parecoxib might improve postoperative pain relief in patients receiving total knee arthroplasty.

Interventions

Analgesic effects of intravenous parecoxib have been investigated in orthopedic surgery. Postoperative pain is still a common problem after total knee arthroplasty. The purpose of this double-blind, randomized study was to investigate whether the addition of intraarticular bupivacaine to intravenous parecoxib could improve pain relief in patients receiving total knee arthroplasty. One hour before operation, a single dose of parecoxib 40 mg was injected intravenously within 30 seconds. After the

Analgesic effects of intravenous parecoxib have been investigated in orthopedic surgery. Postoperative pain is still a common problem after total knee arthroplasty. The purpose of this double-blind, randomized study was to investigate whether the addition of intraarticular bupivacaine to intravenous parecoxib could improve pain relief in patients receiving total knee arthroplasty. One hour before operation, a single dose of parecoxib 40 mg was injected intravenously within 30 seconds. After the closure of the surgical wound, a single dose of intraarticular injection of 0.5% bupivacaine 60 ml (300 mg) was given into the joint space within 2 minutes.

Sponsors

Huang-Ping Yu
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

patient with knee osteoarthritis who was indicated for total knee arthroplasty

Exclusion criteria

neuropathic pain or sensory disorder in the knee required surgery, coagulation abnormalities, severe renal or hepatic impairment, and chronic opioid use

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 5, 2026